title: Effects of selective H.E.L.P. LDL-apheresis on plasma inflammatory markers concentration in severe dyslipidemia: Implication for anti-inflammatory response.
abstract: Therapeutic plasmapheresis is a recognized medical procedure in which various techniques are used to separate and remove undesirable or excessively elevated plasma elements from blood. The main purpose of the procedure is to remove the substances responsible for the disease (autoantibodies, circulating immune complexes, lipoproteins and other molecules) from the patient's blood. Low-Density-Lipoproteins-apheresis (LDL_a) is the selective removal of all apolipoprotein-B100-containing lipoproteins: LDL, very low-density lipoprotein, and lipoprotein (a). They are lowered acutely by 65-75%. There is little effect on other plasma lipidic and non-lipidic components. LDL_a was reported to increase resistance of LDL to oxidation, counteract procoagulatory state and relief disturbances of hemorheology associated with atherosclerosis. These effects are likely to be regarded as to be pleiotropic effects. In the sense that they are not necessarily related to the apolipoprotein-B100-containing lipoproteins level in plasma. There is robust evidence that LDL_a can induce the stabilization of atherosclerotic plaques through its lipid-lowering action. However, other effects unrelated to the apolipoprotein-B100-containing lipoproteins extracorporeal removal, such as the decrease of cytokines and adhesion molecules induced by LDL_a were also reported. Altogether these actions are thought to favorably influence regression of florid, nonfibrous atherosclerotic lesions through a blockade of lipid deposition in the vessel wall, plaque stabilization, and ultimately, coronary and extracoronary artery disease progression. This brief review provides some indication on existing evidence of Heparin-induced Extracorporeal Low-density-lipoprotein Precipitation LDL_a effects on plasma mediators of inflammation.
authors.affiliation: Endocrinology and Metabolic Diseases, Civile Maggiore Hospital of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, P.le Stefani, 37126 Verona, Italy.
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Zenti
authors.forename: Zenti Maria
authors.initials: ZM
authors.lastname: Grazia
authors.forename: Claudia
authors.initials: C
authors.lastname: Stefanutti
authors.forename: Stefanutti
authors.initials: S
authors.lastname: Claudia
mesh_terms: D015415:Biomarkers / Q000097:blood; D001781:Blood Component Removal; D011232:Chemical Precipitation; D050171:Dyslipidemias / Q000097:blood*; D006801:Humans; D007249:Inflammation / Q000097:blood*; D008077:Lipoproteins, LDL / Q000302:isolation & purification*
chemical_list: D015415:Biomarkers; D008077:Lipoproteins, LDL